Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy - An updated review

Leukemia and Lymphoma

Volumn 45, Issue 5, 2004, Pages 905-910

  Ballen, Karen K ^a   Colvin, Gerald ^b   Porter, David ^c   Quesenberry, Peter J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ROGER WILLIAMS MEDICAL CENTER   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cellular immune therapy; Leukemia; Transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY; VINCRISTINE;

ADULT; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOLOGIC MALIGNANCY; HISTOCOMPATIBILITY; HUMAN; INFUSION; LOW ENERGY RADIATION; LYMPHOCYTE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SIBLING; SOLID TUMOR; STATISTICAL ANALYSIS; WHOLE BODY RADIATION;

ANTIGENS, CD3; HEMATOLOGIC NEOPLASMS; HUMANS; LYMPHOCYTE TRANSFUSION; SALVAGE THERAPY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 1842450534     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001628167     Document Type: Review

References (39)

1. Stewart, F.M., Crittenden, R.B., Lowry, P.A., Pearson-White, S. and Quesenberry, P.J. (1993) "LOng-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice", Blood, 81, 2566-2571.
2. Stewart, F.M., Zhong, S., Wuu, J., Hsieh, C.C., Nilsson, S.K. and Quesenberry, P.J. (1998) "LYmphohematopoietic engraftment in minimally myeloablated hosts", Blood, 91, 3681-3687.
3. Quesenberry, P.J., Zhong, S., Wang, H. and Stewart, F.M. (2001) "ALlogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice", Blood, 97, 557-564.
4. Micklem, H.S., Clarke, C.M., Evans, E.P. and Ford, C.E. (1968) "FAte of chromosome-marked mouse bone marrow cells transfused into normal syngeneic recipients", Transplantation, 6, 299.
5. Brecher, G., Ansell, J.D., Micklem, H.S., Tjio, J.H. and Cronkite, E.P. (1982) "SPecial proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice", PNAS (USA), 79, 5085.
6. Saxe, D., Boggs, S.S. and Boggs, D.R. (1984) "TRansplantation of chromosomally marked syngeneic marrow cells into mice not subjected to hematopoietic stem cell depletion", Exp. Hematol., 12, 277.
7. Blomberg, M.E., Rao, S., Reilly, J.L., Tiarks, C.Y., Peters, S.O., Kittler, E.L.W., et al. (1998) "REpetitive bone marrow transplantation in nonmyeloablated recipients", Exp. Hematol., 26, 320-324.
8. Lambert, J.F., Colvin, G.A., Zhong, S., Wang, H., D'Hondt, L., Abedi, M., et al. (2002) "H-2 Mismatched transplantation with repetitive cell infusions and CD40 ligand antibody infusions without myeloablation", Brit. J. Hematol., 119, 155-163.
9. Abedi, M., Greer, D., Lambert, J.F., Colvin, G.A., Dooner, M.S., McAuliffe, C.I., et al. (2003) "TOlerance Induction by costimulator blockade in 100 cGy treated hosts with varying degrees of genetic disparity", Leukemia, (in press).
10. Sullivan, K.M., Storb, R., Buckner, C.D., et al. (1989) "GRaft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms", N. Engl. J. Med., 320, 828-834.
11. Kolb, H.J., Schattenberg, A., Goldman, J.M., et al. (1995) "GRaft-vs-leukemia effect of donor lymphocyte infusions in marrow grafted patients", Blood, 86, 2041-2050.
12. Porter, D.L., Roth, M.S., McGarigle, C., et al. (1994) "INduction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia", N. Engl. J. Med., 330, 100-106.
13. Slavin, S., Nagler, A., Naparstek, E., et al. (1998) "NOnmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases", Blood, 91, 756-763.
14. Khouri, I.F., Saliba, R.M., Giralt, S.A., et al. (2001) "NOnablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: Low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality", Blood, 98, 3595-3599.
15. Dey, B.R., McAfee, S., Colby, C., et al. (2003) "IMpact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation", Biol. Blood Marrow Trans., 9, 320-329.
16. Spitzer, T.R., McAfee, S., Sackstein, R., et al. (2000) "INtentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies", Biol. Blood Marrow Trans., 6, 309-320.
17. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., et al. (2001) "HEmatopoietic cell transplantation in older patients with hematologic malignancies replacing high-dose cytotoxic therapy with graft-versus-tumor effects", Blood, 97, 3390-3400.
18. Dey, B.R., McAfee, S., Sackstein, R., et al. (2001) "SUccessful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation", Biol. Blood Marrow Trans., 7, 604-612.
19. Porter, D.L., Luger, S.M., Duffy, K.M., et al. (2001) "ALlogeneic cell therapy for patients who relapse after autologous stem cell transplantation", Biol. Blood Marrow Trans., 7, 230-238.
20. Porter, D.L., Connors, J.M., Van Deerlin, V.M., et al. (1999) "GRaft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancy", J. Clin. Oncol., 17, 1234-1237.
21. Ballen, K.K., Becker, P.S., Emmons, R.V.B., et al. (2002) "LOw-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy", Blood, 100, 442-450.
22. Schipper, R.F., D'amaro, J. and Oudshoorn, M. (1996) "THe probability of finding a suitable related donor for bone marrow transplantation in extended families", Blood, 87, 800-804.
23. Rubinstein, P., Dobrila, I., Rosenfield, R.E., et al. (1995) "PRocessing and cryopreservation of placental-umbilical cord blood for unrelated marrow reconstitution", Proc. Natl. Acad. Sci. USA, 92, 10119-10122.
24. Ballen, K.K., Wilson, M., Valinski, H., et al. (2000) "BIgger isMbetter: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units", Bone Marrow Transplantation, 27, 7-14.
25. Ballen, K.K., Hicks, J., Dharan, B., et al. (2002) "RAcial and ethnic composition of volunteer cord blood donors: Comparison with volunteer unrelated marrow donors", Transfusion, 42, 1279-1284.
26. Kurtzberg, J., Laughlin, M., Graham, M.L., et al. (1996) "PLacental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients", N. Engl. J. Med., 335, 157-166.
27. Locatelli, F., Rocha, V., Chastang, C., et al. (1999) "FActors associated with outcome after cord blood transplantation in children with acute leukemia", Blood, 93, 3662-3671.
28. Grewal, S.S., Barker, J.N., Davies, S.M., et al. (2003) "UNrelated donor hematopoietic cell transplaMtation: marrow or umbilical cord blood?", Blood, 101, 4233-4244.
29. Daly, A., McAfee, S., Dey, B., et al. (2003) "NOnmyeloablative bone marrow transplaItation: infectious complications in 65 recipients of HLA-identical and mismatched transplants", Biol. Blood Marrow Trans., 9, 373-382.
30. Kanda, Y., Chiba, S., Hirai, H., et al. (2003) "ALlogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)", Blood, 102, 1541-1547.
31. Sykes, M., Preffer, F., McAfee, S., et al. (1999) "MIxed lymphohematopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone marrow transplantation", Lancet, 353, 1755-1759.
32. Colvin, G.A., Lambert, J.F., Lum, L.G., et al. (2002) "THe haplo-immunostorm syndrome: A new clinical entity observed in minimal immunotherapy with outpatient haploidentical bone marrow transplantation", Blood, 100, 411a (abstract).
33. Colvin, G.A., Rathore, R., Lambert, J.F., et al. (2003) "HLA-haploidentical stem cell infusions for refractory hematologic malignancies: A universal outpatient immunotherapeutic approach in 100 cGy treated patients. In: Autologous Blood and Marrow Transplantation, edited by Karel Dicke and Armand Keating, Carden Jennings Publishing Co. In press.
34. Childs, R., Chernoff, A., Contentin, N., et al. (2000) "REgression of metastatic renal cell carcinoma after non-myeloablative allogeneic peripheral stem cell transplantation", J. Clin. Oncol., 17, 2044.
35. Bregni, M., Dodero, A., Peccatori, J., et al. (2002) "NOnmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer", Blood, 99, 4234-4236.
36. Bay, J.O., Choufi, B., Pomel, C., et al. (2000) "POtential allogeneic graft-versus-tumor effect in a patient with ovarian cancer", Bone Marrow Transplantation, 25, 681-682.
37. Liebowitz, L., Lee, K.P. and June, C.H. (1998) "COstimulatory approaches to adoptive immunotherapy", Current Opin. Oncol., 10(6), 553-541.
38. Porter, D., Bunin, N., Laport, G., et al. (2001) "GRaft-versus-tumor induction with donor leukocyte infusions expanded ex-vivo by activation with CD3/CD28 stimulation", Blood, 98, 404a (abstract).
39. Porter, D.L. (2003) "DOnor leukocyte infusions in acute myelogeneous leukemia", Leukemia, 17, 1035-1037.